JPY 1619.0
(0.12%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Operating Cash Flow | 147 Million | -277.85 Million | 67.4 Million | -68.88 Million | 278.97 Million |
Net Income | 66 Million | 63.2 Million | -201.9 Million | -200.8 Million | 127.89 Million |
Depreciation & Amortization | 104 Million | 119.34 Million | 142.34 Million | 143.91 Million | 160.85 Million |
Deferred income taxes | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - |
Change in working capital | -107 Million | -386.3 Million | 59.6 Million | 236.81 Million | 118.27 Million |
Other non-cash items | 84 Million | -6.57 Million | 111.62 Million | -149.96 Million | -7.74 Million |
Investing Cash Flow | 60 Million | 49.49 Million | 46.58 Million | -8.93 Million | 7.95 Million |
Investments in PPE | -27 Million | -41.17 Million | -38.77 Million | -84.59 Million | -147.16 Million |
Acquisitions | 4.17 Million | 19 Thousand | - | - | 14 Thousand |
Investment purchases | -438.36 Million | -536.61 Million | -536.72 Million | -536.71 Million | -536.64 Million |
Sales/Maturities of investments | 522.18 Million | 530 Million | 530 Million | 530 Million | 605.84 Million |
Other Investing Activities | 87 Million | 1.74 Million | -1.43 Million | -3.8 Million | -223 Thousand |
Financing Cash Flow | -100 Million | 98.96 Million | -55.15 Million | 90.68 Million | -60.23 Million |
Debt repayment | -100 Million | -98.97 Million | -55.13 Million | -126.4 Million | -59.83 Million |
Dividends payments | - | -2000.00 | -4000.00 | -6.91 Million | -320 Thousand |
Common Stock Repurchased | - | - | -15 Thousand | -28.8 Million | -74 Thousand |
Common Stock Issuance | - | - | - | - | - |
Other Financing Activities | -100 Million | -1000.00 | -1000.00 | -2000.00 | -1000.00 |
Accounts receivables | 11 Million | -266 Million | -49 Million | 315 Million | 68 Million |
Accounts payables | 67.12 Million | 22.2 Million | 265.53 Million | -342.22 Million | -117.29 Million |
Inventory | -55 Million | -201.5 Million | -163.97 Million | 294.53 Million | 93.68 Million |
Other working capital | -63 Million | -35 Million | 60 Million | -203 Million | -62 Million |
Cash at beginning of period | 727.21 Million | 856.6 Million | 797.77 Million | 784.89 Million | 558.2 Million |
Cash at end of period | 834.91 Million | 727.21 Million | 856.6 Million | 797.77 Million | 784.89 Million |
Capital Expenditure | -27 Million | -41.17 Million | -38.77 Million | -84.59 Million | -147.16 Million |
Effect of forex changes on cash | - | - | - | - | - |
Net cash flow / Change in cash | 107.7 Million | -129.39 Million | 58.83 Million | 12.87 Million | 226.69 Million |
Free Cash Flow | 120 Million | -319.02 Million | 28.62 Million | -153.47 Million | 131.81 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 16 Million | -17 Million | 66.22 Million | 7 Million | 26 Million | 72 Million |
Depreciation & Amortization | - | - | 104.34 Million | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | 52.15 Million | - | - | - |
Other non-cash items | -16 Million | 17 Million | 109.53 Million | -7 Million | -26 Million | -72 Million |
Investing Cash Flow | - | - | 60.08 Million | - | - | - |
Investments in PPE | - | - | -28 Million | - | - | - |
Acquisitions | - | - | 4.17 Million | - | - | - |
Investment purchases | - | - | -438.36 Million | - | - | - |
Sales/Maturities of investments | - | - | 522.18 Million | - | - | - |
Other Investing Activities | - | - | 92 Thousand | - | - | - |
Financing Cash Flow | - | - | -100 Million | - | - | - |
Debt repayment | - | - | -100 Million | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | -100 Million | - | - | - |
Accounts receivables | - | - | 11.94 Million | - | - | - |
Accounts payables | - | - | 67.12 Million | - | - | - |
Inventory | - | - | -55.02 Million | - | - | - |
Other working capital | - | - | 28.1 Million | - | - | - |
Cash at beginning of period | - | - | 727.21 Million | - | - | - |
Cash at end of period | - | - | 834.91 Million | - | - | - |
Capital Expenditure | - | - | -28 Million | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | 107.7 Million | - | - | - |
Free Cash Flow | - | - | 119.61 Million | - | - | - |
5577
CUB
GBBKR
002098
AUTN
PANACEABIO